China Resources Medical Holdings Company Limited provided consolidated earnings guidance for the six months ended June 30, 2023. For the period, the company expects profit for the period attributable to owners of the parent company of the Group as contained in the consolidated financial statements for the Reporting Period would increase by approximately 60% as compared with the restated figures for the corresponding period in year 2022. The increase was mainly attributable to the consolidation arrangement regarding the LH Subjects and the JE Subject where the Group will retrospectively consolidate the financial results of the LH Subjects and the JE.
China Resources Medical Holdings Company Limited
Equities
1515
KYG2133W1087
Healthcare Facilities & Services
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.12 HKD | -0.24% | +8.14% | -14.52% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.52% | 684M | |
-20.16% | 16.21B | |
+4.50% | 12.44B | |
+3.98% | 11.58B | |
+9.72% | 10.79B | |
-0.53% | 7.68B | |
+18.43% | 7.2B | |
+4.49% | 6.67B | |
+50.89% | 4.66B | |
-5.12% | 4.25B |
- Stock Market
- Equities
- 1515 Stock
- News China Resources Medical Holdings Company Limited
- China Resources Medical Holdings Company Limited Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2023